The 2018 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop held in September featured a session titled “Statistical Leadership: Its Importance, Imperatives, and Impacts.” The session consisted of two presentations representing industry and regulatory perspectives on statistical leadership.

